Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.570
-0.120 (-7.10%)
At close: Dec 20, 2024, 4:00 PM
1.770
+0.200 (12.74%)
After-hours: Dec 20, 2024, 7:57 PM EST
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $20.17 million as of December 20, 2024.
Market Cap
20.17M
Enterprise Value
17.09M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $20.17M, a decrease of -39.59%. That is a compound annual growth rate of -85.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 20.17M | -39.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 22.14M |
| Allurion Technologies | 22.08M |
| GeoVax Labs | 21.89M |
| NeurAxis | 21.79M |
| Pulmatrix | 21.59M |
| Cocrystal Pharma | 21.36M |
| Equillium | 21.26M |
| Athira Pharma | 21.19M |